Applying new strategies for the national adaptation, updating, and dissemination of trustworthy guidelines: Results from the Norwegian adaptation of the antithrombotic therapy and the prevention of thrombosis, 9th Ed: American college of chest physicians evidence-based clinical practice guidelines

Chest

Volumn 146, Issue 3, 2014, Pages 735-761

  Kristiansen, Annette ^a,b,c   Brandt, Linn ^a,b,c   Agoritsas, Thomas ^d   Akl, Elie A ^d,e   Berge, Eivind ^f   Jacobsen, Anne Flem ^g   Granan, Lars Petter ^g,h   Halvorsen, Sigrun ^g   Guyatt, Gordon ^d   Vandvik, Per Olav ^a,b,i  

^a INNLANDET HOSPITAL TRUST   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Deacon Hospital   (Norway)

^d MCMASTER UNIVERSITY   (Canada)

^e AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

ⁱ NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; APIXABAN; CLOPIDOGREL; DABIGATRAN; DIPYRIDAMOLE; FONDAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; PRASUGREL; RIVAROXABAN; TICAGRELOR; WARFARIN; FIBRINOLYTIC AGENT;

ADAPTATION; ARTICLE; DEEP VEIN THROMBOSIS; ETHNIC GROUP; EVIDENCE BASED PRACTICE; HEALTH CARE PERSONNEL; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INCIDENCE; INFORMATION DISSEMINATION; NORWAY; NORWEGIAN; PATIENT PREFERENCE; POINT OF CARE TESTING; PRACTICE GUIDELINE; PREVALENCE; RISK BENEFIT ANALYSIS; EVALUATION STUDY; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; PROCEDURES; REPRODUCIBILITY; RISK FACTOR; STANDARDS; THROMBOSIS;

EVIDENCE-BASED MEDICINE; FEASIBILITY STUDIES; FIBRINOLYTIC AGENTS; HUMANS; PRACTICE GUIDELINES AS TOPIC; REPRODUCIBILITY OF RESULTS; RISK FACTORS; THROMBOSIS;

EID: 84907200783     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2993     Document Type: Article

References (31)

1. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ; for the American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidencebased clinical practice guidelines. Chest. 2012;141(2-suppl):7S-47S.
2. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ; GRADE Working Group. What is "quality of evidence" and why is it important to clinicians? BMJ. 2008; 336 (7651): 995-998.
3. Guyatt GH, Oxman AD, Kunz R, et al; GRADE Working Group. Going from evidence to recommendations. BMJ. 2008; 336 (7652): 1049-1051.
4. Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336 (7650): 924-926.
5. Vandvik PO, Brandt L, Alonso-Coello P, et al. Creating clinical practice guidelines we can trust, use, and share: a new era is imminent. Chest. 2013; 144 (2): 381-389.
6. Treweek S, Oxman AD, Alderson P, et al; DECIDE Consortium. Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on Evidence (DECIDE): protocol and preliminary results. Implement Sci. 2013; 8: 6.
7. Kristiansen A, Brandt L, Agoritsas T, et al. Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process. Chest. 2014;146(3):727-734.
8. Agoritsas T, Kristiansen A, Agarwal A, et al. Updating and monitoring of clinical practice guidelines: performance of McMaster Premium LiteratUre Service (PLUS) in identifying new key studies. Chest. In press. doi:10.1378/chest.14-1366.
9. Cohen AT, Spiro TE, Büller HR, et al. Rivaroxban for thromboprophylaxis in acutely ill medical patients. N Eng J Med. 2013; 368(6): 513-523.
10. Goldhaber SZ, Leizorovicz A, Kakkar AK, et al. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med. 2011;365(23):2167-2177.
11. Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med. 2007;146(4):278-288.
12. Di Nisio M, Porreca E, Ferrante N, et al. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Cochrane Database of Systematic Reviews. 2012;2:CD008500.
13. Enden T, Haig Y, Kløw NE, et al; Longterm outcome after additional catheterdirected thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012; 379: 31-38.
14. Adam SS, McDuffie JR, Ortel TL, Williams JW Jr. Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review. Ann Intern Med. 2012;157(11):796-807.
15. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988;318(18):1162-1173.
16. Merli G, Spiro TE, Olsson CG, et al; Enoxaparin Clinical Trial Group. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med. 2001;134(3):191-202.
17. Homma S, Thompson JL, Pullicino PM, et al; WARCEF investigators. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012;366(20):1859-1869.
18. Farge D, Debourdeau P, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost. 2013;11(1):56-70.
19. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2-suppl):e278S-e325S.
20. Januel J-M, Chen G, Ruffi eux C, et al; IMECCHI Group. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review. JAMA. 2012; 307 (3): 294-303.
21. Husted H, Otte KS, Kristensen BB, Ørsnes T, Wong C, Kehlet H. Low risk of thromboembolic complications after fast-track hip and knee arthroplasty. Acta Orthop. 2010; 81 (5): 599-605.
22. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988; 318 (18): 1162-1173.
23. Neumann I, Rada G, Claro JC, et al. Oral direct Factor Xa inhibitors versus lowmolecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and metaanalysis. Ann Intern Med. 2012; 156 (10): 710-719.
24. Pedersen AB, Mehnert F, Johnsen SP, Husted S, Sorensen HT. Venous thromboembolism in patients having knee replacement and receiving thromboprophylaxis: a Danish population-based follow-up study. J Bone Joint Surg Am. 2011; 93 (14): 1281-1287.
25. Bates SM. Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2-suppl):e691S-e736S.
26. Shiffman RN, Dixon J, Brandt C, et al. The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation. BMC Med Inform Decis Mak. 2005; 5: 23.
27. Gagliardi AR, Brouwers MC, Palda VA, Lemieux-Charles L, Grimshaw JM. How can we improve guideline use? A conceptual framework of implementability. Implement Sci. 2011; 6 (1): 26
28. Grimshaw JM, Eccles MP, Lavis JN, Hill SJ, Squires JE. Knowledge translation of research findings. Implement Sci. 2012; 7 (1): 50
29. Flottorp SA, Oxman AD, Krause J, et al. A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice. Implement Sci. 2013; 8 (1):
30. Cook DA, Sorensen KJ, Hersh W, Berger RA, Wilkinson JM. Features of effective medical knowledge resources to support point of care learning: a focus group study. PLoS One. 2013; 8 (11): e80318.
31. DYNAM-IT. MAGIC website. http://www. magicproject.org/dynam-it. Accessed December 2013.